✦ LIBER ✦

Budget Impact of Switching Pramipexole Immediate Release to Pramipexole Extended Release in Treatment of Parkinson’s Disease; Perspective of the Social Security Institution

✍ Scribed by Kececioglu, S.; Ulus, P.; Cukadar, F.; Urganci, B.; Ozkan, M.

Book ID: 122179159
Publisher: John Wiley and Sons
Year: 2013
Tongue: English
Weight: 60 KB
Volume: 16
Category: Article
ISSN: 1098-3015
DOI: 10.1016/j.jval.2013.08.1815

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy, safety, and tolerability of ov

Efficacy, safety, and tolerability of overnight switching from immediate- to once daily extended-release pramipexole in early Parkinson's disease

✍ Olivier Rascol; Paolo Barone; Robert A. Hauser; Yoshikuni Mizuno; Werner Poewe; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB 👁 1 views

## Abstract The aim of this article is to test the feasibility, in early Parkinson's disease (PD), of an overnight switch from immediate‐release (IR) pramipexole to a new once‐daily extended‐release (ER) formulation. Nonfluctuating patients on pramipexole IR three‐times daily, alone or with levodop

Success rate, efficacy, and safety/toler

Success rate, efficacy, and safety/tolerability of overnight switching from immediate- to extended-release pramipexole in advanced Parkinson's disease

✍ A. H. V. Schapira; P. Barone; R. A. Hauser; Y. Mizuno; O. Rascol; M. Busse; C. D 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 540 KB

P2.155 Simple overnight switching from i

P2.155 Simple overnight switching from immediate- to extended-release pramipexole in early Parkinson's disease at the same daily dosage

✍ O. Rascol; P. Barone; R. Hauser; Y. Mizuno; W. Poewe; A. Schapira; C. Debieuvre; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 76 KB